摘要
目的:探讨 CEA-rV对巨噬细胞抗原提呈功能的影响。方法:采用混合淋巴细胞反应(MLR)检测 Mφ的抗原提呈功能,采用流式细胞仪(FCM)检测Mφ表面分子MHC-Ⅰ(H-2Kb)、MHC-Ⅱ(Ⅰ-Ab)及B7(B7-2)的表达,采用荧光抗体直接染色法检测肿瘤细胞表面H-2Kb、Ⅰ-Ab的表达。结果:CEA-rV接种小鼠腹腔Mφ组(CEA-rVMφ组)T细胞分泌IL-2的水平较W-VV及VS组显著增强(P<0.01),小鼠腹腔Mφ自身表达的Ⅰ-Ab和B7-2分子较低(分别为41.7%,13.7%),接种W-VV后其Ⅰ-Ab及B7-2分子表达改变不明显(分别为44.3%,15.l%),而接种 CEA-rV后其Ⅰ-Ab及 B7-2分子表达明显增强(分别为 87.2%,39.5%)。各组CEA阳性肿瘤细胞表面分子MHC-Ⅰ强表达,却没有 MHC-Ⅱ表达。结论:CEA-rV腹腔接种 Mφ可使 Mφ抗原提呈功能显著增强,Mφ的表面分子MHC-Ⅱ与B7-2表达增强可能是其抗原提呈功能增强的主要原因。提示MHC-Ⅱ与B7-2可能在CEA-rV抗瘤中发挥重要作用。
Objective: To investigate the effect of CEA-rV on antigen-presenting ability of macrophage( Mφ). Methods :In this study, the antigen-presenting ability of Mφ was detected by mix lymphocyte reaction ( MLR) , the expressions of cell surface molecules MHC-Ⅰ(H-2Kb)、MHC-Ⅱ(I-Ab) and B7(B7-2) on mouse Mφ were detected by flow-cytometry (FCM),and the expressions of H-2Kb and I-Ab on CEA positive tumor cell surface were detected by direct fluorescence antibody staining. Results: IL-2 level from T cells incubated with CEA-rV Mφ was significantly increased compared to that of W-VV group or NS group ( P < 0. 01 ). The expressions of I-Ab and B7-2 on mouse Mφ.treated with CEA-rV were significantly increased (87.2% and 39.5 % respectively) compared to that on W-VV treated Mφ(44.3% and 15. 1% respectively) or Hanks treated Mφ(41.7% and 13.7% respectively) ,while there was no significant difference in the expression of H-2K between different groups. Strong MHC-Iexpression, but not MHC-Ⅱ expression on the CEA positive tumor cellswere revealed by routine fluorescence-activated immunohistochemistry analysis,and there was no difference between the CEA-rV treated group.Hanks treated group and W-VV treated group. Conclusion: It could be deduced that CEA-rV enhances the antigen-presenting ability of CEA-rV Mφ which may due to the upregulaion of the expression of I-Ab.B7-2 on CEA-rV Mφ. I-Ab and B7-2 may play important roles in anti-tumor of CEA-rV.
出处
《广州医学院学报》
2002年第1期4-7,共4页
Academic Journal of Guangzhou Medical College
基金
广州市科委基金资助项目(No.JB02-98-5-018-01)
广东省卫生厅资助课题(No.A1998127)
广州医学院资助课题(No.2000-GK-14)
广州医学院博士启动基金资助课题